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Abstract 1 
 2 
Background/Objectives: Some obese adults have a normal metabolic profile and are 3 
considered ‘healthy’, but whether they experience faster ageing than healthy normal-weight 4 
adults is unknown. We compared decline in physical function, worsening of bodily pain, and 5 
likelihood of future mobility limitation and disability between these groups. 6 
Subjects/Methods: This was a population-based observational study using repeated 7 
measures over 2 decades (Whitehall II cohort data). Normal-weight (body mass index (BMI) 8 
18.5-24.9kg/m²), overweight (25.0-29.9kg/m²), and obese (≥30.0kg/m2) adults were 9 
considered metabolically healthy if they had 0 or 1 of 5 risk factors (hypertension, low high-10 
density lipoprotein cholesterol, high triacylglycerol, high blood glucose, and insulin 11 
resistance) in 1991/94. Decline in physical function and worsening of bodily pain based on 12 
change in Short Form Health Survey items using 8 repeated measures over 18.8 years 13 
(1991/94-2012/13) was compared between metabolic-BMI groups using linear mixed 14 
models. Odds of mobility limitation based on objective walking speed (slowest tertile) and of 15 
disability based on limitations in ≥1 of 6 basic activities of daily living, each using 3 repeated 16 
measures over 8.3 years (2002/04-2012/13), were compared using logistic mixed models.  17 
Results: In multivariable-adjusted mixed models on up to 6635 adults (initial mean age 50 18 
years; 70% male), healthy normal-weight adults experienced a decline in physical function of 19 
-3.68 (95% CI=-4.19, -3.16) score units per decade; healthy obese adults showed an 20 
additional -3.48 (-4.88, -2.08) units decline. Healthy normal-weight adults experienced a -21 
0.49 (-0.12, 1.11) score unit worsening of bodily pain per decade; healthy obese adults had 22 
an additional -2.23 (-0.69, -3.78) units worsening. Healthy obesity versus healthy normal-23 
weight conferred 3.39 (2.29, 5.02) times higher odds of mobility limitation and 3.75 (1.94, 24 
7.24) times higher odds of disability. 25 
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Conclusions: Our results suggest that obesity, even if metabolically healthy, accelerates 26 
age-related declines in functional ability and poses a threat to independence in older age. 27 
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Introduction 28 
 29 
Obesity is a considered a serious threat to public health (1). Health risks of obesity are 30 
largely mediated through disruptions to metabolism which emerge in response to excess fat 31 
(2) and which may subsequently lead to type 2 diabetes, cardiovascular diseases, and 32 
premature mortality (3-5). As many as one-in-three obese adults at any given time however 33 
present without metabolic dysfunction in the form of metabolic risk factor clustering and are 34 
considered ‘healthy’ (6, 7). This healthy subset was initially assumed to be protected from 35 
the adverse health consequences typical of obesity, but have since demonstrated strong 36 
tendencies to become insulin resistant (8), to progress to unhealthy obesity (9), and to 37 
develop type 2 diabetes (10), and cardiovascular disease (11-13) all at greater rates than 38 
normal-weight adults who are similarly healthy.  39 
To our knowledge, excess risk for outcomes related to aging among healthy obese 40 
adults has not been examined, although such evidence would form an important basis from 41 
which to advise on weight loss. Obesity is strongly linked with musculoskeletal impairments 42 
(5, 14) which often manifest clinically as osteoarthritis of the hip or knee (15, 16), one of the 43 
greatest and most enduring sources of pain, disability, and diminished quality of life at older 44 
ages (17, 18). The presence of metabolic risk factors and high systemic inflammation may 45 
compound these adverse effects (19, 20), but given that the primary mechanism is thought 46 
to be mechanical strain placed on joints by excess fat (14), obesity with or without metabolic 47 
dysfunction may be hypothesised to limit physical function to a similar degree. One study 48 
found that both healthy and unhealthy obese adults showed a higher likelihood of developing 49 
difficulties with walking or climbing stairs over a 7-year period than healthy normal-weight 50 
adults, suggesting worsened physical function in response to obesity itself (21). This finding 51 
has not been replicated and risk of other important age-related outcomes such as bodily pain 52 
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and disability have not been compared between healthy obese and healthy normal-weight 53 
adults.   54 
Using repeated measures over two decades in a well-characterised British cohort, 55 
the Whitehall II study, we aimed to compare long-term changes in two key indicators of 56 
functional ability - physical function and bodily pain – between middle-aged adults who were 57 
initially healthy obese and healthy normal-weight. We also compared the long-term risk of 58 
having a mobility limitation and of being disabled between these groups in order to examine 59 
potential for loss of independence.  60 
 61 
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Subjects and Methods 62 
 63 
Study population 64 
 65 
Longitudinal data were drawn from the Whitehall II cohort study which recruited 66 
London-based men and women employed by the British government in 1985/88 (22). 67 
Questionnaire data are collected every 2-3 years, and clinical data are collected every 5 68 
years. A combination of questionnaire data and clinical data from 8 repeated assessments 69 
over 2 decades (baseline in 1991/94; follow-up extending until 2012/2013) were used for 70 
present analyses. The University College London research ethics committee granted ethical 71 
approval for each phase of data collection. Participants provided written informed consent.  72 
 73 
Assessment of metabolic and obesity status 74 
 75 
Data from a 1991/94 clinical assessment was used to determine participants’ initial 76 
obesity and metabolic status. Height and weight were measured objectively by a nurse and 77 
used to calculate body mass index (BMI) using the formula: weight (kilograms) / height 78 
(meters)-squared. Based on World Health Organization BMI classifications (23), participants 79 
were considered either ‘normal-weight’ (18.5-24.9kg/m²), ‘overweight’ (25.0-29.9kg/m²), or 80 
‘obese’ (≥30.0kg/m2). Participants considered ‘underweight’ (BMI <18.5kg/m2) were excluded 81 
from analyses due to their rarity (n=72, 0.87% of the sample). Based on independent criteria 82 
(6), participants were also considered ‘healthy’ if they had 0 or 1 of the following 5 metabolic 83 
risk factors: high density lipoprotein (HDL) cholesterol <1.03 mmol/l for men and <1.29 84 
mmol/l for women or use of lipid lowering medication; blood pressure ≥130/85 mmHg or use 85 
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of anti-hypertension medication; fasting plasma glucose ≥5.6 mmol/l or use of anti-diabetic 86 
medication; triacylglycerol≥ 1.7 mmol/l; homeostatic model assessment (HOMA) of insulin-87 
resistance (fasting glucose*fasting insulin/22.5) >3.20 (90th-percentile value in 1991/94).  88 
 89 
Assessment of physical function and bodily pain 90 
 91 
Participants were asked to answer a series of 36 question items covering several 92 
domains of general health from the Short Form Health Survey (SF-36) at the time of 93 
metabolic and obesity status assessment (1991/94) and at 7 subsequent occasions (in 94 
1995/96, 1997/99, 2001, 2002/04, 2006, 2007/09, and 2012/13). Domains assessed by the 95 
SF-36 have been shown to be valid measures of overall health status in the general 96 
population (24) and of change in overall health status in the Whitehall II cohort (25).  97 
Assessment of physical function was based on a sub-domain comprised of 10 items 98 
from the SF-36 which pertained to physical function over the past 4 weeks. Participants 99 
reported whether they considered their health to limit basic tasks including vigorous activities 100 
(I.e. running), moderate activities (I.e. housework), lifting or carrying groceries, climbing 101 
several flights of stairs, or movements which involve bending, kneeling, and stooping. 102 
Response options for each item ranged from ‘not limited at all’ to ‘limited a lot’.  103 
The assessment of bodily pain was based on another sub-domain comprised of 2 104 
items from the SF-36 which pertained to perceptions of bodily pain during the past 4 weeks, 105 
which asked participants to report how much bodily pain they experienced (response options 106 
ranging from ‘none’ to ‘very severe’) and how much this pain interfered with their normal 107 
work inside and outside of the home (response options ranging from ‘not at all’ to 108 
‘extremely’).  109 
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Responses on each sub-domain were summed and scaled from 0 to 100 based on 110 
standard procedures for the SF-36 (26), with higher scores representing better function/less 111 
bodily pain. Summary scores for each of physical function and bodily pain at all 8 112 
measurement occasions were used to estimate change over time, with decreasing scores 113 
indicating worsened physical function/bodily pain.  114 
 115 
Assessment of mobility limitation and disability 116 
 117 
Mobility limitation was assessed on 3 occasions after assessment of metabolic and 118 
obesity status (in 2002/04, 2007/09, and 2012/13). On each occasion, participants undertook 119 
a test of walking speed based on standard protocol (27), for which they completed a timed 120 
walk at their usual walking pace over a distance of 8 feet while wearing low-heeled 121 
closefitting footwear or while barefoot. Timing commenced once their foot hit the floor across 122 
the starting line, and stopped once their foot hit the floor after the end of the walking course. 123 
The test was repeated three times and the mean performance time of these three 124 
measurements was used for present analyses, measured in seconds (s). Based on 125 
established links with morbidity and mortality (27-30), participants were considered to have a 126 
mobility limitation on each occasion if they were in the slowest (versus the 127 
intermediate/fastest) tertile of walking speed.  128 
Disability was also assessed on 3 occasions after assessment of metabolic and 129 
obesity status (in 2006, 2007/08, and 2012/13). On each occasion, participants reported via 130 
questionnaire whether they considered themselves to have difficulty with any of 6 basic 131 
activities of daily living (31) (dressing, walking across a room, bathing/showering, eating, 132 
getting in/out of bed, and using the toilet). Participants were considered ‘disabled’ if they 133 
reported ≥ 1 (versus 0) limitation in any activity.  134 
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 135 
Assessment of covariates 136 
 137 
Covariates were assessed via questionnaire at the same time as metabolic and 138 
obesity status in 1991/94. Participant age, sex, and ethnicity (‘white’ or ‘non-white’) were 139 
recorded in addition to social status based on occupational position in the British government 140 
(‘administrative’, ‘professional/executive’, or ‘clerical/support’). Assessment of health 141 
behaviours included cigarette smoking status (‘never smoker’,  ‘ex-smoker’, or ‘current 142 
smoker’), alcohol consumption in the previous week (‘abstainer’ based on 0 units/week, 143 
‘moderate drinker’ based on 1-14 units/week for women and 1-21 units/week for men, or 144 
‘high drinker’ based on >14 units/week for women, >21 units/week for men),  frequency of 145 
fruit and vegetable consumption (‘less than daily or daily’, or ‘twice or more per day’), and 146 
physical activity that was assessed by self-reported duration (hours per week) in activities of 147 
a moderate or vigorous intensity.  148 
 149 
Statistical analyses 150 
 151 
Linear mixed models were used to compare mean change in physical function and 152 
bodily pain scores over 8 measurement occasions, along with 95% confidence intervals (CI), 153 
by initial metabolic and obesity status in 1991/94, each compared with the healthy normal-154 
weight group. These models minimise selection bias from missing data by using data from 155 
all available follow-up occasions while accounting for differences in duration of follow-up and 156 
the correlated nature of repeated measures taken from the same individuals over time (32). 157 
Follow-up duration was used as the time variable, divided by 10 so that regression 158 
coefficients represent effects for change over 10 years. A random intercept and a random 159 
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slope were fitted to allow individual differences in initial physical function/bodily pain score 160 
and change in these scores over time. Absolute change in each score was also calculated 161 
for each metabolic and obesity group based on intercept values taken at the reference 162 
groups of categorical covariates (for men; white ethnicity; administrative/highest 163 
occupational position; never smokers; moderate drinkers; at least twice-daily consumers of 164 
fruits and vegetables) and age centred on the sample mean (50 years). Predictors in the first 165 
model included metabolic and BMI status combination (6 groups), time, age, sex, and 166 
ethnicity, each with time interactions fitted where significant. Predictors in the second model 167 
considered those of the first in addition to occupational position, smoking, alcohol, fruit and 168 
vegetable consumption, and moderate-to-vigorous physical activity, each with time 169 
interactions where significant. 170 
Logistic mixed models were used to compare odds of having a mobility limitation and 171 
of having a disability between metabolic and BMI combination groups, each compared with 172 
healthy normal-weight. These models minimise selection bias due to missing data for the 173 
same reasons as mentioned for linear mixed models (32). Duration of follow-up was again 174 
used as the time variable with time expressed per 5 years instead of per 10 years due to 175 
shortened follow-up. The same 2-stage model adjustment strategy was otherwise applied as 176 
prior.  177 
As some ethnic heterogeneity existed in the sample yet precise ethnic labels were 178 
not available for ascribing ethnic-specific BMI categories, analyses were repeated after 179 
excluding the 9% of participants who were of a non-white ethnicity. Analyses of change in 180 
physical function and bodily pain were also repeated after excluding those participants with 181 
only 1 available measure out of 8 on each outcome. 182 
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Results 183 
 184 
Selection and characteristics of the study population 185 
 186 
The Whitehall II cohort originally consisted of 10308 participants recruited in 1985/88 187 
(22). Of this original sample, 6641 participants (64.4%) had complete data on height and 188 
weight for the assessment of BMI and on each of 5 metabolic risk factors of interest as 189 
measured in the 1991/94 clinical examination. Of these, 6 participants were excluded due to 190 
missing data on each of 8 follow-up measures of physical function or bodily pain. All 191 
remaining participants had data on basic covariates for initial adjustments (age, sex, and 192 
ethnicity). We excluded a further 392 participants from models adjusted for occupational 193 
position and health behaviours due to missing data on these covariates. Sample attenuation 194 
patterns were similar for outcomes of mobility limitation and disability, with the exception of a 195 
larger reduction (1306 participants) from the 6641 with BMI-metabolic data due to missing 196 
data on either outcome; data collection for these began later than for physical function and 197 
bodily pain.  198 
Compared with participants who had metabolic-BMI data (the initial prerequisite for 199 
inclusion) and also had data on mobility (n=5507), those who had metabolic-BMI data but 200 
had missing data on mobility (n=1134) were older (51.10 vs 49.22 years, p<0.001), more 201 
likely to be female (34.7% vs 28.22%, p<0.001), more likely to be of a non-white ethnicity 202 
(13.32% vs 8.52%, p<0.001), and more likely to be of the lowest occupational position 203 
(27.12% vs 13.31%, p<0.001). Those with missing mobility data also had a higher smoking 204 
prevalence (21.21% vs 11.82%, p<0.001) and a higher likelihood of consuming fruit and 205 
vegetables less than daily (46.47% vs 37.43%, p<0.001), but were no less likely to consume 206 
high amounts of alcohol (14.11% vs 15.74%, p=0.168) or to be less physically active (3.35 207 
vs 3.56 hours/week, p=0.104). Participants with missing mobility data showed a higher 208 
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prevalence of obesity (12.61% vs 9.42%, p=0.001) and of metabolic risk factor clustering 209 
(39.42% vs 32.61%, p<0.001). These comparison estimates were nearly identical among 210 
participants with vs without missing data on disability (Appendix).  211 
In total, up to 6635 participants contributed data for analyses, with the working 212 
sample size varying due to the nature of mixed modelling. Age of participants ranged from 213 
39-63 years at the baseline assessment (mean 49.5 years) and 70.1% were men. Of the 214 
3339 adults who were normal-weight, 80.5% were considered metabolically healthy; this 215 
proportion decreased with increasing BMI group: 56.3% of 2634 overweight adults were 216 
healthy, and 34.0% of 662 obese adults were healthy. Further characteristics of participants 217 
who had complete data on metabolic and obesity status in 1991/94 and at least 1 measure 218 
of physical function and bodily pain are shown in Table 1. Of those who had physical 219 
function and bodily pain scores at baseline, those who were healthy obese had lower (more 220 
adverse) scores than healthy normal-weight adults, these differences being substantial at 221 
83.3 vs. 92.1 for physical function, and 77.2 vs. 83.0 for pain (both p<0.05). 222 
 223 
Change in physical function and bodily pain 224 
 225 
Nearly all participants (n=6537; 98.5%) had data on at least 2 of 8 measures for 226 
physical function from which to base estimates of change (3707 participants, 55.9%, had 227 
data on all 8 measures). The interaction term between sex, metabolic-BMI group, and time in 228 
relation to physical function was not significant (p=0.925), indicating similar changes in 229 
physical function by metabolic-BMI group in both men and women. Over a mean follow-up of 230 
18.8 years, decline in physical function score was seen among all metabolic and BMI 231 
combination groups over the follow-up period (Table 2). When adjusting for basic 232 
demographic factors, the healthy obese showed an additional -3.42 (95% CI=-4.80, -2.03) 233 
units decline per 10 years in physical function score than healthy normal-weight adults; this 234 
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difference remained after additional adjustment for occupational position and health 235 
behaviours (-3.48, 95% CI=-4.88, -2.08 units; Figure 1). This decline was nearly 2-times 236 
greater than among healthy normal-weight adults ((3.68 + 3.48) / 3.68 = 1.95). The greatest 237 
decline was seen among unhealthy obese adults (additional -5.02, 95% CI=-6.06, -3.98 238 
units) compared with healthy normal-weight adults, but this was not significantly greater than 239 
for healthy obese adults (p=0.068). Non-significant interaction terms of time with sex, alcohol 240 
consumption, physical activity, and fruit and vegetable consumption were removed from 241 
these models.   242 
Again, nearly all participants (n=6538; 98.5%) had data on at least 2 of 8 measures 243 
for bodily pain from which to base estimates of change (3699 participants, 55.8%, had data 244 
on all 8 measures). No strong evidence for an interaction between sex, metabolic-BMI 245 
group, and time in relation to bodily pain was observed (p=0.054). A worsening of bodily pain 246 
score was also seen among all metabolic and obesity groups over follow-up (Table 2). This 247 
worsening was greater among healthy obese compared with healthy normal-weight adults 248 
when considering basic demographics (difference in 10-year change=-2.15, 95% CI=-3.66, -249 
0.63 units); this difference remained after additional adjustment for social and behavioural 250 
factors (-2.23, 95% CI=-3.78, -0.69 units; Figure 1), equating to nearly a 6-times greater 251 
worsening than that of healthy normal-weight adults ((0.48 + 2.23)) / 0.48 = 5.65). The 252 
greatest worsening was seen among unhealthy obese adults (difference in 10-year 253 
change=-4.10, 95% CI=-5.24, -2.95 compared with healthy normal-weight); there was weak 254 
evidence of this being greater than for the healthy obese (p=0.045). A non-significant 255 
interaction term of time with physical activity was removed from these models.   256 
 257 
Odds of mobility limitation and disability 258 
 259 
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Among 6641 participants whose metabolic and BMI status was assessed in 1991/94, 260 
up to 5507 (82.9%) had at least 1 assessment of mobility limitation over a mean observation 261 
period of 8.3 years (3841 participants (57.8%) had all 3 assessments). The proportion of 262 
adults who had a mobility limitation over follow-up was lowest among healthy normal-weight 263 
adults at 29.1%, and highest among healthy obese and unhealthy obese adults, at 60.1% 264 
and 56.7% respectively. Differences in odds of mobility limitation by metabolic and obesity 265 
group did not differ over follow-up (p for interaction of metabolic and BMI combination with 266 
time = 0.36) and so this time interaction was removed; likewise for sex and ethnicity (p-267 
values for interaction with time = 0.099 and 0.175 respectively). Compared with healthy 268 
normal-weight adults, healthy obese adults showed 3.92 (95% CI=2.64, 5.80) times higher 269 
odds of having a mobility limitation over follow-up when adjusting for demographics; odds 270 
remained 3.39 (95% CI=2.29, 5.02) times higher when additionally adjusting for social and 271 
behavioural factors (Figure 2; Table 3). Raised odds of mobility limitation were highest 272 
among unhealthy obese adults at 4.01 (95% CI=2.98, 5.40) times higher than healthy 273 
normal-weight adults, however this was not significantly higher than the healthy obese 274 
(p=0.48).  275 
Among 6641 participants whose metabolic and BMI status was assessed in 1991/94, 276 
up to 5616 (84.6%) had at least 1 assessment of disability over a mean observation period 277 
of 5.6 years (4434 participants (66.8%) had all 3 assessments). The proportion of adults who 278 
had a disability over follow-up was lowest among healthy normal-weight adults at 9.1%, and 279 
progressively higher among healthy obese and unhealthy obese adults at 18.6% and 27.0% 280 
respectively. Again, a non-significant interaction of metabolic and BMI combination with time 281 
(p=0.34) provided no evidence that differences in odds of disability by metabolic and obesity 282 
group changed over follow-up, this time interaction was therefore removed; likewise for all 283 
other covariates except for age which reached significance (p-value for interaction with time 284 
<0.001). Compared with healthy normal-weight adults, healthy obese adults were 3.84 (95% 285 
CI=2.01, 7.34) times more likely to be disabled when adjusting for basic demographic 286 
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factors; these odds remaining elevated at 3.75 (95% CI=1.94, 7.24) times higher when 287 
additionally adjusting for social and behavioural factors (Figure 2; Table 3). The highest 288 
raised odds were seen among unhealthy obese adults (OR=8.37, 95% CI=5.25, 13.35 vs. 289 
healthy normal-weight), there was some evidence of this being higher than for healthy obese 290 
adults (p=0.03).  291 
 292 
Sensitivity analyses 293 
 294 
Results of sensitivity analyses are provided in Appendix. Results of analyses that 295 
excluded the 9% of participants who were of a non-white ethnicity were largely unchanged; 296 
as were results of analyses of change in physical function and bodily pain that excluded 297 
participants with only 1 measurement of each outcome. A larger participant drop-out was 298 
observed for mobility limitation and disability than for physical function and bodily pain; a 299 
comparison of characteristics between included versus excluded participants for these 300 
former outcomes is given in Appendix.  301 
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Discussion 302 
 303 
This study of 6635 men and women examined whether obese adults who are metabolically 304 
healthy experience faster ageing than normal-weight adults who are similarly healthy by way 305 
of greater declines in physical function, greater worsening of bodily pain, and higher 306 
likelihoods of having a mobility limitation and disability in older age. Our results showed that 307 
over the course of 2 decades, decline in physical function and worsening of bodily pain 308 
among initially healthy obese adults was 2- and 6-times greater than among initially healthy 309 
normal-weight adults respectively. These changes occurred at similar rates for both healthy 310 
and unhealthy obese adults. A comparably higher likelihood of having a mobility limitation 311 
and of being disabled was also observed. This suggests that obesity, even if metabolically 312 
healthy, accelerates age-related declines in functional ability and poses a threat to 313 
independence in older age.  314 
Comparisons of walking speed between healthy obese and healthy normal-weight 315 
groups is novel; only 1 previous study of women found that the healthy obese performed 316 
better than the unhealthy obese on a timed test of walking distance, but comparisons were 317 
not made with the healthy normal-weight (33). That study was also limited by a small sample 318 
size (total n=86) and a single measurement occasion; the present study considered 3 319 
measurement occasions of walking speed spanning nearly a decade to provide a better 320 
estimate of usual walking capacity.  321 
The likelihood of being disabled was somewhat lower among healthy obese than 322 
among unhealthy obese adults, but the difference between these 2 groups was small and 323 
not likely significant in terms of disability burden. Indeed, healthy obese adults are known to 324 
have a strong tendency to progress to an unhealthy obese state; this proportion is about 325 
one-half in the Whitehall II cohort after 20 years (9). Importantly, these progressions to 326 
unhealthy obesity occur at greater rates among adults who are initially healthy obese than 327 
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among adults who are either healthy or unhealthy non-obese, likely reflecting causal effects 328 
of higher BMI on metabolic dysfunction and of higher BMI on lower physical activity as 329 
supported by Mendelian randomisation studies (23, 34, 35).  330 
Similar to previous studies, healthy obesity was defined here using an array of 331 
metabolic risk factors which are commonly measured in clinical settings, and such 332 
classifications based on the binary presence or absence of blood-based risk factors using 333 
cut-points may offer clinical relevance at the expense of scientific precision. Indeed, 334 
descriptive characteristics of participants at first measurement showed that healthy obese 335 
adults had more adverse levels of most metabolic risk factors than healthy normal-weight 336 
adults despite both groups being classified as ‘healthy’; this is commonly observed across 337 
studies in this area. We did not analyse the already established associations of healthy 338 
obesity with metabolic decline (9), type 2 diabetes (10), cardiovascular disease (13), or other 339 
chronic diseases (36) as these are expected to mediate and not confound associations with 340 
functional outcomes. We considered only those activities of daily living which were 341 
considered basic and not instrumental in assessing disability because basic activities are 342 
thought to be more closely related to functional status and are more severe and limiting, 343 
whereas instrumental activities such as one’s ability to manage money often relate more to 344 
cognitive functioning and are less severe and limiting as these can more readily be adapted 345 
to with informal caregiving.  346 
 347 
Strengths and limitations 348 
 349 
Change in 2 key indicators of functional status were examined utilising up to 8 350 
repeated measures over a follow-up period spanning 2 decades, providing a more 351 
comprehensive view of long-term change than previously possible. Mixed modelling was 352 
performed to make maximum use of all available data over the long follow-up period and to 353 
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minimise the effects that selection bias due to missing data can have on results. The extent 354 
of missing data was largest for mobility and disability outcomes, with participants missing on 355 
these outcomes appearing more socioeconomically disadvantaged and less behaviourally 356 
and physically healthy than those with complete data; however the impact of this selection 357 
bias is expected to be more modest here given the use of repeated measures on outcomes 358 
compared to what would be expected if a more restrictive sample was used for complete 359 
case analyses.  The indicators of physical function and bodily pain used were also based on 360 
self-reported questionnaire items which are subject to biases in reporting and individual 361 
subjectivity; however both objective and self-reported measures were used to assess 362 
functional limitations in the form of mobility limitation and disability, allowing for internal 363 
validation of self-reported findings and improved consistency of results.  364 
 365 
Conclusions 366 
 367 
Our results suggest that obesity, even if metabolically healthy, accelerates age-368 
related declines in functional ability and poses a threat to independence in older age. Long-369 
term decline in physical function was nearly 2-times greater, and worsening of bodily pain 370 
nearly 6-times greater, among obese adults who are metabolically healthy than among 371 
normal-weight adults who are similarly healthy. The likelihood of developing a mobility 372 
limitation and of becoming disabled was also nearly 4-times greater among healthy obese 373 
than among healthy normal-weight adults. Weight loss is therefore still advisable for healthy 374 
obese adults for the purpose of preserving the quality of later life.  375 
 376 
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Figure titles and legends 
 
Figure 1 Title Decline in physical function and worsening of bodily pain over 2 decades by 
initial metabolic and obesity status 
 
Figure 1 Legend Models include adjustment for 1991/94 values of age, sex, ethnicity, 
occupational position, moderate-to-vigorous physical activity, smoking, alcohol, and fruit and 
vegetable consumption. 
 
Figure 2 Title Likelihood of having a mobility limitation and of being disabled over 1 decade 
by initial metabolic and obesity status 
 
Figure 2 Legend Models include adjustment for 1991/94 values of age, sex, ethnicity, 
occupational position, moderate-to-vigorous physical activity, smoking, alcohol, and fruit and 
vegetable consumption. 
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 Table 1 Characteristics of participants in 1991/94 by metabolic and obesity status in the Whitehall II cohort study (n=6635) 
       
 
Healthy  
normal-weight 
(n=2688)  
Unhealthy 
normal-weight 
(n=651) 
Healthy 
overweight 
(n=1482)  
Unhealthy 
overweight 
(n=1152) 
Healthy  
obese 
(n=225) 
Unhealthy 
obese 
(n=437) 
       
Female – n (%)  863 (32.1) 89 (13.7)* 481 (32.5) 193 (16.8)* 148 (65.8)* 172 (39.4)* 
Age, years – mean (SD)  48.7 (6.0) 50.2 (6.0)* 49.5 (5.9)* 50.8 (6.0)* 49.7 (5.8)* 50.3 (5.9)* 
Non-white ethnicity – n (%)  185 (6.9) 78 (12.0)* 139 (9.4)* 126 (10.9)* 42 (18.7)* 48 (11.0)* 
Lowest occupational position – n (%)  357 (13.3) 73 (11.2) 268 (18.1)* 168 (14.7) 64 (28.7)* 104 (24.1)* 
Consumes fruit and vegetables < daily – n (%)  947 (35.2) 264 (40.6)* 584 (39.4)* 512 (44.4)* 77 (34.2) 198 (45.3)* 
Current smoker – n (%)  320 (12.6) 93 (14.9) 183 (13.2) 154 (14.2) 31 (14.6) 56 (13.7) 
High alcohol consumption in previous week – n (%)  353 (13.2) 111 (17.1)* 236 (16.0)* 222 (19.4)* 31 (14.0) 68 (15.8) 
Moderate-to-vigorous physical activity, hrs/wk– mean (SD)  3.7 (4.1) 3.5 (3.9) 3.6 (4.2) 3.6 (4.0) 2.7 (3.1)* 2.7 (3.2)* 
Systolic blood pressure, mmHg – mean (SD)  115.9 (12.0) 127.5 (14.6)* 118.7 (11.2)* 128.0 (13.0)* 121.0 (13.5)* 130.6 (12.7)* 
Diastolic blood pressure, mmHg – mean (SD)  76.2 (8.4) 83.8 (8.9)* 79.0 (8.1)* 85.6 (8.6)* 80.6 (9.4)* 87.1 (8.9)* 
Fasting glucose, mmol/l – mean (SD)  5.1 (0.4) 5.6 (0.9)* 5.1 (0.4) 5.6 (0.8)* 5.0 (0.4) 5.7 (1.3)* 
HOMA insulin resistance – mean (SD)  1.0 (0.8) 1.8 (1.3)* 1.4 (0.8)* 2.5 (2.1)* 1.7 (1.0)* 4.1 (4.5)* 
Triacylglycerol, mmol/l – mean (SD)  1.0 (0.4) 2.0 (1.2)* 1.2 (0.5)* 2.2 (1.2)* 1.2 (0.5)* 2.3 (1.2)* 
HDL cholesterol, mmol/l – mean (SD)  1.6 (0.4) 1.2 (0.4)* 1.5 (0.3)* 1.2 (0.3)* 1.5 (0.3)* 1.2 (0.3)* 
Body mass index, kg/m² – mean (SD)  22.6 (1.6) 23.4 (1.3)* 26.7 (1.3)* 27.2 (1.4)* 32.4 (2.5)* 33.4 (3.4)* 
Initial physical function score 
a 
– mean (SD)  92.1 (12.1) 90.9 (13.1) 89.6 (14.6)* 89.0 (14.1)* 83.3 (17.9)* 81.5 (18.4)* 
Initial bodily pain score 
a 
– mean (SD)  83.0 (19.0) 83.3 (18.5) 81.2 (20.2)* 82.4 (19.4) 77.2 (21.8)* 77.5 (22.5)* 
       
Participants described are those with data on metabolic and obesity status and at least 1 measurement of physical function and bodily pain. *Different from healthy 
normal-weight (p<0.05); 
a 
Based on participants with a physical function and pain score in 1991/94 
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 Table 2 Decline in physical function and worsening of bodily pain per decade by initial 
metabolic and obesity status in the Whitehall II cohort study 
 
 Decline in physical function per 10 years
1 
 
   
 Model 1 Model 2 
 B (95% CI) B (95% CI) 
   
Decline in healthy normal-weight  -4.27 (-4.68, -3.86) -3.68 (-4.19, -3.16) 
   
Healthy normal-weight (n=2569) 0.00 (reference) 0.00 (reference) 
Unhealthy normal-weight (n=615) -0.74 (-1.60, 0.12) -0.61 (-1.47, 0.26) 
Healthy overweight (n=1420) -0.68 (-1.30, -0.06) -0.54 (-1.18, 0.09) 
Unhealthy overweight (n=1070) -1.48 (-2.17, -0.78) -1.22 (-1.92, -0.52) 
Healthy obese (n=205) -3.42 (-4.80, -2.03) -3.48 (-4.88, -2.08) 
Unhealthy obese (n=401) -5.18 (-6.20, -4.17) -5.02 (-6.06, -3.98) 
   
 Worsening of bodily pain per 10 years
1
 
   
 Model 1 Model 2 
 B (95% CI) B (95% CI) 
   
Worsening in healthy normal-weight  -1.15 (-1.60, -0.71) -0.49 (-1.11, 0.12) 
   
Healthy normal-weight (n=2560) 0.00 (reference) 0.00 (reference) 
Unhealthy normal-weight (n=616) -0.54 (-1.48, 0.39) -0.36 (-1.31, 0.60) 
Healthy overweight (n=1412) -1.23 (-1.91, -0.56) -1.10 (-1.80, -0.41) 
Unhealthy overweight (n=1070) -1.55 (-2.30, -0.79) -1.31 (-2.09, -0.53) 
Healthy obese (n=208) -2.15 (-3.66, -0.63) -2.23 (-3.78, -0.69) 
Unhealthy obese (n=403) -4.35 (-5.46, -3.24) -4.10 (-5.24, -2.95) 
   
1 
Lower scores indicate worsened function/pain. Model 1 adjusted for age, sex, and 
ethnicity in 1991/94. Model 2 additionally adjusted for occupational position, moderate-to-
vigorous physical activity, smoking, alcohol, and fruit and vegetable consumption in 
1991/94. Reference group for intercept is men in these analyses; interaction terms with 
sex were non-significant and findings were similar when analyses were repeated with 
women as the reference (Appendix). 
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Table 3 Odds of disability and mobility limitation among adults over 8.3 years by initial 
metabolic and obesity status in the Whitehall II cohort study  
 
 Odds of having a mobility limitation
1
 
   
 Model 1 Model 2 
 Odds ratio (95% CI) Odds ratio (95% CI) 
   
Healthy normal-weight (n=2023) 1.00 (reference) 1.00 (reference) 
Unhealthy normal-weight (n=448) 1.22 (0.95, 1.56) 1.13 (0.88, 1.45) 
Healthy overweight (n=1101) 1.44 (1.21, 1.71) 1.31 (1.10, 1.56) 
Unhealthy overweight (n=812) 1.85 (1.52, 2.25) 1.57 (1.28, 1.91) 
Healthy obese (n=148) 3.92 (2.64, 5.80) 3.39 (2.29, 5.02) 
Unhealthy obese (n=275) 4.58 (3.41, 6.13) 4.01 (2.98, 5.40) 
   
 Odds of having a disability
2
 
   
 Model 1 Model 2 
 Odds ratio (95% CI) Odds ratio (95% CI) 
   
Healthy normal-weight (n=2250) 1.00 (reference) 1.00 (reference) 
Unhealthy normal-weight (n=502) 0.83 (0.51, 1.33) 0.77 (0.47, 1.25) 
Healthy overweight (n=1208) 1.72 (1.25, 2.36) 1.70 (1.22, 2.36) 
Unhealthy overweight (n=901) 2.22 (1.57, 3.14) 2.13 (1.49, 3.04) 
Healthy obese (n=161) 3.84 (2.01, 7.34) 3.75 (1.94, 7.24) 
Unhealthy obese (n=333) 8.89 (5.64, 14.00) 8.37 (5.25, 13.35) 
   
1
Mobility limitation defined as being in the slowest vs. fastest/intermediate tertile of 
walking speed. 
2
Disabled defined as having ≥ 1 out of 6 limitations in basic activities of 
daily living. Model 1 adjusted for age, sex, and ethnicity in 1991/94. Model 2 additionally 
adjusted for occupational position, moderate-to-vigorous physical activity, smoking, 
alcohol, and fruit and vegetable consumption in 1991/94. 
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